IPDx, in 2016, was awarded a grant from Sächsische Aufbaubank to develop multi-biomarker point of care tests targeting different types of cancer.
IPDx Diagnostics OÜ‘s project (EU53347) „Preliminary studies for ImmunoHealth diagnostics service
platform“ is supported by Norway Grants Green ICT small scheme programme, aiming to stimulate and
develop innovation-led long-term business cooperation between Estonia and Norway. The small scheme
project is necessary to prepare for the main call project in order to develop a solution ImmunoHealth
that enables to predict type 2 diabetes in early stage by utilizing immunoprofiling based disease and
health risk diagnostics solution. Green ICT small scheme project is necessary to assess feasibility of the
project, map certification requirements, carry out business studies and put together development plan
for the platform. The implementation period is 01.07.2019 – 31.10.2019.
IPDx joined the EIT health network in 2019 and we are currently finalist in the 2019 European health catapult program.
IPDx has been granted the SME instrument to further illustrate the symbiosis between the microbiome and immunome. With this project we will demonstrate how to easily monitor changes of the microbiome via antibody profiles while also being able to influence microbiome compositions.